The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 06, 2026
Snapshot (as of Sep 06, 2026): Becton, Dickinson and Company (BDXB) pays a $3.00 annual dividend ($0.75 quarterly), yielding 6.23% at $48.16/share. Next ex-dividend date 2023-02-14. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 6.23%
Annual Dividend: $3.00 per share
Payout Ratio: 124.4%
Ex-Dividend Date: 2023-02-14
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 4
Becton, Dickinson and Company dividend currently yields 6.23%, making it one of the higher-yielding names in the healthcare sector. BD designs and distributes medical supplies, laboratory instruments, and diagnostic systems, serving hospitals, clinical labs, and life science researchers worldwide. The trailing annual dividend rate is $3.00 per share, paid quarterly, with the most recent ex-dividend date of February 14, 2023. At a beta of 0.564, BDXB stock moves well below the broader market, which appeals to income-focused investors who prioritize lower price volatility.
Becton, Dickinson and Company pays out 124.4% of earnings as dividends, a payout ratio classified as high (above 75%). BD's portfolio spans essential medical products, including IV systems, syringes, automated diagnostic instruments, and surgical tools, categories that see recurring demand across healthcare institutions globally, which provides a degree of revenue support for the current payment level. Becton, Dickinson and Company dividend safety is the central concern here: a payout ratio above 100% means the dividend currently exceeds reported earnings, and any sustained earnings pressure would put the $3.00 annual rate at risk.
Becton, Dickinson and Company dividend history shows a CAGR of 0.0% per year from 2021 to 2022. The per-share annual dividend held flat at $3.00 across both complete years in the data window. The smallest annual increase in the window was 0.0% in 2022. Growth is nonexistent in the available data, which means income investors are receiving yield without any dividend expansion to offset inflation.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | -21.4% | $1.54 (2020) | $0.75 (2023) |
BDXB fits income-focused investors who want a high current yield from a global medical technology business. The yield of 6.23% sits well above the 5-year average of 4.67%, a gap that reflects the elevated payout ratio rather than a change in the underlying dividend rate. The yield classification is high (above 4%), but the 124.4% payout ratio is the defining trade-off: the income is substantial, and the business serves essential healthcare markets, but the dividend currently exceeds earnings. An investor in Becton, Dickinson and Company stock gets a high nominal yield with zero recent dividend growth and meaningful payout pressure baked in.
| Payment Date | Amount per Share |
|---|---|
| 2023-02-14 | $0.7500 |
| 2022-11-14 | $0.7500 |
| 2022-08-12 | $0.7500 |
| 2022-05-12 | $0.7500 |
| 2022-02-14 | $0.7500 |
| 2021-11-12 | $0.7500 |
| 2021-08-12 | $0.7500 |
| 2021-05-13 | $0.7500 |
| 2021-02-11 | $0.7500 |
| 2020-11-12 | $0.7500 |
| Year | Total Dividends |
|---|---|
| 2023 | $0.7500 |
| 2022 | $3.0000 |
| 2021 | $3.0000 |
| 2020 | $1.5420 |
Project income from BDXB with the BDXB dividend calculator or track your full portfolio with the dividend tracker.